Company: INMB
Filing Date: 2025-08-07
Form Type: 8-K
Source: 0001213900-25-073089
Chunk: 2

Company: Inmune Bio, Inc.
Filing Date: 2025-08-07
Form: 8-K
Item: Item 9.01
Chunk 2
---
Item 9.01 Financial statements and Exhibits

(d) Exhibits.

  99.1      Press Release, dated August 7, 2025                                          
  99.2      Press Release, dated August 4, 2025                                          
 ─────────────────────────────────────────────────────────────────────────────────────────
   104      Cover Page Interactive Data File (embedded within the Inline XBRL document)  

SIGNATURES

Pursuant to the requirements of the Securities
Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly
authorized.

                            INMUNE BIO INC.                                   
  Date: August 7, 2025      By:                  /s/ David Moss               
                                                 David Moss                   
                                                 Principal Executive Officer